t helper cells in ibd
DESCRIPTION
T helper cells in IBD. Jaimee Doucette. Overview. Background Information on T Helper cells What is known about Th cells in IBD? What is still unknown about Th cells in IBD? Paper 1 Paper 2 Future studies/specific aims. T cells . Nature Reviews Immunology 2 , 309-322 (May 2002). - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/1.jpg)
J A I M E E D O U C E TT E
T HELPER CELLS IN IBD
![Page 2: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/2.jpg)
OVERVIEW
• Background Information on T Helper cells• What is known about Th cells in IBD?• What is still unknown about Th cells in IBD?• Paper 1• Paper 2• Future studies/specific aims
![Page 3: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/3.jpg)
T CELLS
Nature Reviews Immunology 2, 309-322 (May 2002)
![Page 4: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/4.jpg)
ACTIVATION OF NAÏVE T HELPER CELLS
http://www.ncbi.nlm.nih.gov/books/NBK26827/figure/A4531/?report=objectonly
Differentiate into effector T cells by the secretion of cytokines
T helper cells recognize MHC Class II through their TCR MHC Class II present exogenous antigen
![Page 5: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/5.jpg)
Main Role in Adaptive Immunity
Activate infected macrophages
Provide help for B cell Ab production; switching to IgE
Increase neutrophil response
Suppressor T cells
https://www.caymanchem.com/app/template/Article.vm/article/2177
![Page 6: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/6.jpg)
EFFECTOR T HELPER CELLS
http://www.ncbi.nlm.nih.gov/pubmed/19362058
![Page 7: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/7.jpg)
OVERVIEW
• Background Information on Helper T cells• What is known about Th cells in IBD?• What is still unknown about Th cells in IBD?• Paper 1• Paper 2• Future studies/specific aims
![Page 8: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/8.jpg)
http://www.ncbi.nlm.nih.gov/pubmed/19362058
Classically, Crohn’s Disease was thought to be a Th1 driven disease, while ulcerative colitis was thought to be a Th2 driven disease.
Th17 cells have gained attention in more recent years as playing a role in IBD pathogenesis
![Page 9: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/9.jpg)
There is an apparent increase in IL-17 production in patients with IBD (Fujino, et al.), meaning there must be an increase in Th17 cells
http://onlinelibrary.wiley.com/doi/10.1002/ibd.20894/pdf
IL-23 has been shown to promote the survival of Th17 cells
![Page 10: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/10.jpg)
IL-23 is a cytokine made up of two subunits P40 subunit shared with IL-12 Unique p19 subunit
In IBD, especially in Crohn’s Disease, the role of IL-12 has been focused on
IL-12 promotes the survival of Th1 cells
Since its discovery, many studies of IBD have begun to focus more on IL-23 rather than IL-12
Therapies have begun to emerge targeting IL-23 for treatment of IBD
I chose to focus on IL-23 and its role in IBD
![Page 11: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/11.jpg)
OVERVIEW
• Background Information on Helper T cells• What is known about Th cells in IBD?• What is still unknown about Th cells in IBD?• Paper 1• Paper 2• Future studies/specific aims
![Page 12: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/12.jpg)
Although IL-23 is clearly important in the pathogenesis of IBD, what exact role does it play?
Does is also affect Th1 cells along with Th17 cells?
Questions regarding my topic…
With therapeutics to IL-23, how can they be monitored to see if the treatment is making a difference?
![Page 13: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/13.jpg)
OVERVIEW
• Background Information on Helper T cells• What is known about Th cells in IBD?• What is still unknown about Th cells in IBD?• Paper 1• Paper 2• Future studies/specific aims
![Page 14: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/14.jpg)
PAPER 1
• “IL-23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn’s Disease” by Kobayashi, et. al.
• Goal: Examine the role of IL-23 in IBD in relation to the balance of Th1 and Th17 cells.
![Page 15: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/15.jpg)
http://www.nature.com/nri/journal/v3/n4/fig_tab/nri1057_F1.html
Lamina Propria
Found beneath the epithelial cell layer
Thin layer of loose connective tissue
Part of the mucosa
Rich in immune cells
![Page 16: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/16.jpg)
Figure 1. Physiological distribution of IL17; highly expressed in LP
Conclusion: IL23/IL17 are more prominent and play a more important role in the intestinal mucosal immunity
![Page 17: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/17.jpg)
Figure 2. IL17 upregulation in IBD patients, especially UC
Mucosal tissue specimens Isolated LP CD4+ T cells
![Page 18: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/18.jpg)
Figure 2 (continued).
Conclusions: Levels of IL17 and other Th17 related cytokines (IL21 and IL22) tend to be more enhanced in UC than in CD
![Page 19: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/19.jpg)
Figure 3. Investigation of IL23R, a marker of Th17 cells, on LP CD4+ Tc
Conclusions: Potential Th17 cells exist similarly in both UC and CD patients.
![Page 20: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/20.jpg)
Question: Why is IL17 increased in UC intestinal mucosa compared to CD?
Figure 4. Expression of IL12 family members in whole mucosa of IBD patients
IL12p40 shared between IL12 and IL23
IL23p19 unique to IL23IL12p35 unique to IL12
![Page 21: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/21.jpg)
Figure 5. IL17 production by LP CD4+ Tc after IL23 stimulation
Ulcerative Colitis
Crohn’s Disease
![Page 22: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/22.jpg)
Figure 5 (continued).
Conclusions: Th1 cytokines can affect IL17 production, possibly explaining why IL17 levels were higher in UC than in CD
![Page 23: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/23.jpg)
CONCLUSIONS FROM PAPER 1
Expression levels of IL17 (and other Th17 related cytokines) tend to be higher in IBD patients with UC rather than CD
Potential Th17 cells exist similarly in both UC and CD patients, as shown by the IL23R
There is a positive correlation between IL23 expression and IL17 in UC; there is also a positive correlation between IL23 expression and IFNγ in CD
Exogenous Th1 cytokines (IFNγ and IL12) decrease the production of IL17Therefore, while CD patients may have an upregulation of Th17 cells
as well as UC patients, the characteristic Th1 cytokines may disturb the IL17 production. IL23 may enhance production of distinct cytokines between UC and CD, contributing to the Th1/Th17 balance in IBD.
![Page 24: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/24.jpg)
OVERVIEW
• Background Information on Helper T cells• What is known about Th cells in IBD?• What is still unknown about Th cells in IBD?• Paper 1• Paper 2• Future studies/specific aims
![Page 25: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/25.jpg)
PAPER 2
• Since IL23 may be important in upregulating specific IBD related cytokine production, anti-IL23 therapies have been implemented
• “Biomarkers of Therapeutic Response in the IL-23 Pathway in Inflammatory Bowel Disease” by Cayatte, et. al.
• Goal: Evaluate the effects of mAbs to IL23R, and to identify biomarkers for anti-IL23 therapy in Crohn’s Disease
![Page 26: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/26.jpg)
MOUSE MODELS Anti-CD40 IBD Mouse model, T cell independent; direct activation
of inflammatory dendritic cells and macrophages with a CD40 agonist that mimics activated T cells
C57BL/6 Rag2 -/-
1 day before induction, mice were injected subcutaneously with anti-IL23R mAbs or IgG control antibody
At day 0, mice were administered intravenously with 50 ug of anti-CD40 to induce IBD
C3H/SCID mice, T cell dependent mouse model of IBD
Cecal bacterial antigen (CBA) activated CBA-specific T cells 1 x 106 CBA specific T cells were injected into mice.
Adpotive transfer of CBA-specific Adoptive transfer of anti-CD3 Bir14 CD4+ T cells activated T cells
![Page 27: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/27.jpg)
Figure 1. Candidate biomarker gene expression/protein concentration in mouse colon tissue or feces
![Page 28: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/28.jpg)
Figure 1 (continued).
Anti-CD40 induced IL22, IL17, and TNF alpha treatment with mAbs to IL23R blocked these increases.
Shotgun proteomics analysis identified 57 proteins modulated in disease; 7 were chosen for validation.Selection criteria: up or down regulation in disease, control levels upon IL23R mAb treatment, known association with IBD or IL23, availability of reagents.
![Page 29: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/29.jpg)
Figure 1 (continued).
Conclusions: IL23R therapies can return IBD associated proteins to near control levels
![Page 30: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/30.jpg)
Figure 2. Expression of candidate biomarkers in Tc-dependent mouse model
Preventative Treatment: mAbs given on same day as cell transfer and weekly thereafter
![Page 31: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/31.jpg)
Figure 2 (continued).
Therapeutic Treatment: mAbs given 4 weeks after disease onset and continued for 4 weeks
![Page 32: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/32.jpg)
Figure 3. Regulation of biomarkers by IL17A, IL22, and TNF-alpha in HT-29 cells
Human colonic epithelial cells responsive to IL17 and IL22 stimulation
Absence of IL23R
Conclusion: S100A8/9, PAP, LCN2, DMBT1, and CCL20 are regulated by IL17A, IL22, and TNF-alpha in human colonic epithelial cells
![Page 33: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/33.jpg)
Figure 4. Expression of candidate biomarkers in patients with Crohn’s Disease
![Page 34: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/34.jpg)
Figure 4 (continued).
![Page 35: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/35.jpg)
PAPER 2 CONCLUSIONS
• Inactivation of the IL-23 receptor blocks IBD• Consistent with previous studies blocking p19 itself
• IL23 therapeutic effect shows the potential value in monitoring anti-IL23 therapies
• Calprotectin (S100A8/9), PAP (REG3β/γ), and MIF are elevated in CD• Also, LCN2 and CCL20 • PAP and LCN2 are upregulated in feces of CD patients
• Measuring these markers in serum and stool can serve as a tool for monitoring anti-IL23 therapies
![Page 36: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/36.jpg)
OVERVIEW
• Background Information on Helper T cells• What is known about Th cells in IBD?• What is still unknown about Th cells in IBD?• Paper 1• Paper 2• Future studies/specific aims
![Page 37: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/37.jpg)
FUTURE STUDIES
• Traditionally, Crohn’s Disease is associated with Th1 cells based on the cytokines made
• Recently, IL-23/Th17 pathway has shown to be important for the manifestation of CD as well
• According to a study in Therapeutic Advances in Gastroenterology, therapies using a p40 mAb show great success in CD patients
SPECIFIC AIM:
To determine biomarkers for Crohn’s Disease therapies involving a monoclonal antibody to the p40 subunit of IL-23 and IL-12, representative cytokines of Th17 and Th1 cells, respectively.
Therap Adv Gastroenterol. Mar 2010; 3(2): 99–106.
![Page 38: T helper cells in IBD](https://reader035.vdocuments.mx/reader035/viewer/2022062501/568163f7550346895dd58a30/html5/thumbnails/38.jpg)
REFERENCESAbraham, C., Cho, J. Interleukin-23/Th17 Pathways and Inflammatory Bowel Disease. Inflamm Bowel Dis 2009; 15: 1090-1100
Alberts B, Johnson A, Lewis J, et al. Molecular Biology of the Cell. 4th edition. New York: Garland Science; 2002.
Brock, T. G. (2014). www.caymanchem.com. Retrieved March 11, 2014, from Cayman Chemical: https://www.caymanchem.com/app/template/Article.vm/article/2177
Cayatte, C., et al. Biomarkers of Therapeutic Response in the IL-23 Pathway in Inflammatory Bowel Disease. Clinical and Translational Gastroenterology (2012) 3.
Fujino, S., Andoh, A., Bamba, S., Ogawa, A., Hata, K., Araki, Y., Bamba, T., Fujiyama, Y. Increased expression of interleukin 17 in inflammatory bowel disease. Gut. 2003;52:65-70
Germain, Ronald N. T-cell development and the CD4–CD8 lineage decision. Nature Reviews Immunology 2, 309-322 (May 2002)
Kobayashi, T., et al. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease. Gut. 2008 Dec;57(12):1682-9
Mowat, A. Anatomical basis of tolerance and immunity to intestinal antigens. Nature Reviews Immunology 3, 331-341 (April 2003)
Murphy, K. M. (2011). Janeway's Immunobiology, 8th Edition. Garland Science.
Reenaers, C. Current directions of biologic therapies in inflammatory bowel disease. Therap Adv Gastroenterol. Mar 2010; 3(2): 99–106.
Zenewicz LA, Antov A, Flavell RA. CD4 T-cell differentiation and inflammatory bowel disease. Trends Mol Med. 2009 May;15(5):199-207.